View online Forward to a friend   |   Facebook   |   Twitter
Editorial Focus:
Solid Oral Dose Formulation
Pharmaceutical Outsourcing™
Featured Articles   |   Featured Partners   |   Videos   |   Industry News   |   Events
July 17, 2024
LEARN MORE »
Newsletter Sponsor
   Transforming The Challenges Of Pediatric Drug Formulation Into Product Solutions

Adare has over 30 years’ experience combining expertise, integrated services, and specialized technology platforms to develop optimized pediatric formulations that provide ease of application and improved patient outcomes. From NCEs to product lifecycle extensions, we can deliver flexible and convenient medications for your youngest patients.

more info

» Industry News
learn more
  Celerion’s US Pharmacies Expand On-Site Services
Celerion announced the launch of on-site services for rapid sterility testing (validated alternative... read more »
learn more
  Cambrex to Expand Stability Storage Business with New Facility in Durham, NC
Cambrex announced the expansion of its stability storage business, Q1 Scientific, which offers ... read more »

more news
 
» Featured Articles
EVENT   Roundtable: Pediatric Dosage Forms
Srinivasan Shanmugam, PhD., Executive Director of Pharmaceutical Sciences, Business ... read more »
EVENT   Leveraging Machine Learning and Deep Learning for Natural Language Processing in Clinical Data Management
Machine learning (ML) – and more recently deep learning (DL) – are transforming the field ... read more »
more articles
 
» Featured Video
learn more
  A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules,... read more »

more videos
 
» Featured Thought Leadership
EVENT   Customized Release Through Dispersed Dosage Formats
Pharmaceutical development is as much an art as it is a science, with experts working to find the best solutions and then formulating them in a manner... read more »
EVENT   A New Framework for Identifying Nitrosamine Risks and Efficiently Derisking Products
Since the release of the FDA’s guidance on Nitrosamine Drug Substance-Related Impurities (NDSRIs), the pharmaceutical industry has been diligently ... read more »
EVENT   Streamline Early-Stage Development to Reach the Clinic Faster
It can be easy to overlook the importance of early-stage pharmaceutical product development, viewing it as a series of checklist tasks slowing ... read more »
EVENT   Formulation Considerations for Pediatric Populations
To address the challenges of pediatric formulations, specialized technology platforms are often needed to provide ease of application and improve ... read more »
more articles
 
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA